✦ LIBER ✦

Imatinib pharmacokinetics in CML and ALL patients

Book ID: 120858081
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414350-00042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib effective in paediatric CML and

Imatinib effective in paediatric CML and ALL

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Nilotinib in Imatinib-Resistant CML and

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

✍ Kantarjian, Hagop; Giles, Francis; Wunderle, Lydia; Bhalla, Kapil; O'Brien, Susa 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 186 KB

Dasatinib, nilotinib effective for imati

Dasatinib, nilotinib effective for imatinib-resistant CML and ALL

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Not all imatinib resistance in CML areBC

Not all imatinib resistance in CML areBCR-ABLkinase domain mutations

✍ Yuan Wei; Mats Hardling; Bob Olsson; Rahil Hezaveh; Anne Ricksten; Dick Stockelb 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 147 KB

Imatinib mesylate induces massive and no

Imatinib mesylate induces massive and nonspecific aminoaciduria in cml patients

✍ Jean-Christophe Ianotto; Adrian Tempescul; Yolande Amet; Pauline Grall; Florence 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

young children, who would otherwise require sedation in order to remain still for the duration of a long T 2 -MRI examination. Our results demonstrate that T \* 2 -measured LIC is as reliable as T 2 -derived measurements that are the current non-invasive gold-standard. Furthermore, our T \* 2 method

Random aneuploidy in CML patients at dia

Random aneuploidy in CML patients at diagnosis and under imatinib treatment

✍ A. Amiel; M. Yukla; E. Gaber; L. Leopold; G. Josef; M. Fejgin; M. Lishner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 91 KB